<unk>  is a prostacyclin receptor agonist that is FDA approved for the treatment of patients with pulmonary arterial hypertension (PAH, WHO Group I) to delay disease progression and reduce the risk of hospitalization for PAH.   Common adverse reactions include headache, diarrhea, jaw pain, nausea, myalgia, vomiting, pain in extremity, and flushing (≥5%)..
Selexipag
Prasugrel
Guanadrel
Iproclozide
Bergapten
Crofelemer
Danaparoid
Pancrelipase